KRAS and renal cell carcinoma: This study characterizes the clinical and molecular features of KRAS-mutated Renal Cell Carcinoma (RCC), identifying three distinct subtypes, which arise from different cells of origin and exhibit diverse genomic alterations and metabolic profiles.